BRIEF-ViiV Healthcare presents positive results from 41 week phase IIa ECLAIR study By: Reuters: Company News February 24, 2016 at 12:27 PM EST * Presented positive results from 41 week phase IIa ECLAIR study Read More >> Related Stocks: Gsk Plc ADR Pfizer